CX.ST(CX.ST)
CX.ST
No analyst ratings available
No analyst price targets available for CX.ST
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $853M | $808M | $848M | $880M |
| Low | $853M | $808M | $848M | $880M |
| High | $853M | $808M | $848M | $880M |
| EBITDA Avg | $121M | $114M | $120M | $124M |
| Low | $121M | $114M | $120M | $124M |
| High | $121M | $114M | $120M | $124M |
| EBIT Avg | $77M | $73M | $77M | $80M |
| Low | $77M | $73M | $77M | $80M |
| High | $77M | $73M | $77M | $80M |
| Net Income Avg | $48M | $55M | $66M | $70M |
| Low | $48M | $55M | $66M | $70M |
| High | $48M | $55M | $66M | $70M |
| EPS Avg | $2.52 | $2.92 | $3.50 | $3.71 |
| Low | $2.52 | $2.92 | $3.50 | $3.71 |
| High | $2.52 | $2.92 | $3.50 | $3.71 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $161M | $210M |
| Low | $161M | $210M |
| High | $161M | $210M |
| EBITDA Avg | $23M | $30M |
| Low | $23M | $30M |
| High | $23M | $30M |
| EBIT Avg | $15M | $19M |
| Low | $15M | $19M |
| High | $15M | $19M |
| Net Income Avg | $5M | $17M |
| Low | $5M | $17M |
| High | $5M | $17M |
| EPS Avg | $0.25 | $0.87 |
| Low | $0.25 | $0.87 |
| High | $0.25 | $0.87 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |